Pulmonary Drug Delivery Devices/Systems Market

List of Tables
Table 1. Pulmonary Drug Delivery Devices/Systems CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Pulmonary Drug Delivery Devices/Systems Market Trends
Table 3. Pulmonary Drug Delivery Devices/Systems Market Drivers
Table 4. Pulmonary Drug Delivery Devices/Systems Market Challenges
Table 5. Pulmonary Drug Delivery Devices/Systems Market Restraints
Table 6. Global Pulmonary Drug Delivery Devices/Systems Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Pulmonary Drug Delivery Devices/Systems Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Pulmonary Drug Delivery Devices/Systems Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Pulmonary Drug Delivery Devices/Systems Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Pulmonary Drug Delivery Devices/Systems Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Pulmonary Drug Delivery Devices/Systems Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Manufacturer, 2017-2022
Table 13. Global Pulmonary Drug Delivery Devices/Systems Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Manufacturer, 2017-2022
Table 15. Global Pulmonary Drug Delivery Devices/Systems Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Pulmonary Drug Delivery Devices/Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Pulmonary Drug Delivery Devices/Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Drug Delivery Devices/Systems as of 2021)
Table 18. Top Players of Pulmonary Drug Delivery Devices/Systems in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Pulmonary Drug Delivery Devices/Systems Product Type
Table 20. Date of International Manufacturers Enter into Pulmonary Drug Delivery Devices/Systems Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Pulmonary Drug Delivery Devices/Systems Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Pulmonary Drug Delivery Devices/Systems Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Pulmonary Drug Delivery Devices/Systems Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Pulmonary Drug Delivery Devices/Systems Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Pulmonary Drug Delivery Devices/Systems Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Pulmonary Drug Delivery Devices/Systems Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Pulmonary Drug Delivery Devices/Systems Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Pulmonary Drug Delivery Devices/Systems Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Pulmonary Drug Delivery Devices/Systems Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Pulmonary Drug Delivery Devices/Systems Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Pulmonary Drug Delivery Devices/Systems Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Pulmonary Drug Delivery Devices/Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Pulmonary Drug Delivery Devices/Systems Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Pulmonary Drug Delivery Devices/Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Pulmonary Drug Delivery Devices/Systems Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Pulmonary Drug Delivery Devices/Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Hovione Corporation Information
Table 43. Hovione Description and Business Overview
Table 44. Hovione Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Hovione Pulmonary Drug Delivery Devices/Systems Product
Table 46. Hovione Recent Development
Table 47. 3M Health Care Corporation Information
Table 48. 3M Health Care Description and Business Overview
Table 49. 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. 3M Health Care Product
Table 51. 3M Health Care Recent Development
Table 52. Bespak Corporation Information
Table 53. Bespak Description and Business Overview
Table 54. Bespak Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Bespak Product
Table 56. Bespak Recent Development
Table 57. BeyonDevices Corporation Information
Table 58. BeyonDevices Description and Business Overview
Table 59. BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. BeyonDevices Product
Table 61. BeyonDevices Recent Development
Table 62. GlaxoSmithKline Corporation Information
Table 63. GlaxoSmithKline Description and Business Overview
Table 64. GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. GlaxoSmithKline Product
Table 66. GlaxoSmithKline Recent Development
Table 67. H&T Presspart Corporation Information
Table 68. H&T Presspart Description and Business Overview
Table 69. H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. H&T Presspart Product
Table 71. H&T Presspart Recent Development
Table 72. PARI Respiratory Equipment Corporation Information
Table 73. PARI Respiratory Equipment Description and Business Overview
Table 74. PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. PARI Respiratory Equipment Product
Table 76. PARI Respiratory Equipment Recent Development
Table 77. Philips Respironics Corporation Information
Table 78. Philips Respironics Description and Business Overview
Table 79. Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Philips Respironics Product
Table 81. Philips Respironics Recent Development
Table 82. SHL Corporation Information
Table 83. SHL Description and Business Overview
Table 84. SHL Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. SHL Product
Table 86. SHL Recent Development
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Pulmonary Drug Delivery Devices/Systems Customers List
Table 90. Pulmonary Drug Delivery Devices/Systems Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Pulmonary Drug Delivery Devices/Systems Product Picture
Figure 2. Global Pulmonary Drug Delivery Devices/Systems Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Pulmonary Drug Delivery Devices/Systems Market Size 2017-2028 (US$ Million)
Figure 4. Global Pulmonary Drug Delivery Devices/Systems Sales 2017-2028 (K Units)
Figure 5. United States Pulmonary Drug Delivery Devices/Systems Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Pulmonary Drug Delivery Devices/Systems Market Size 2017-2028 (US$ Million)
Figure 7. United States Pulmonary Drug Delivery Devices/Systems Sales 2017-2028 (K Units)
Figure 8. United States Pulmonary Drug Delivery Devices/Systems Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Pulmonary Drug Delivery Devices/Systems Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Pulmonary Drug Delivery Devices/Systems Report Years Considered
Figure 11. Product Picture of Metered Dose Inhalers
Figure 12. Product Picture of Dry Powder Inhalers
Figure 13. Product Picture of Nebulizers
Figure 14. Product Picture of Accessories
Figure 15. Global Pulmonary Drug Delivery Devices/Systems Market Share by Type in 2022 & 2028
Figure 16. Global Pulmonary Drug Delivery Devices/Systems Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2028) & (K Units)
Figure 19. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Pulmonary Drug Delivery Devices/Systems Price by Type (2017-2028) & (USD/Unit)
Figure 21. United States Pulmonary Drug Delivery Devices/Systems Market Share by Type in 2022 & 2028
Figure 22. United States Pulmonary Drug Delivery Devices/Systems Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Pulmonary Drug Delivery Devices/Systems Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2028) & (K Units)
Figure 25. United States Pulmonary Drug Delivery Devices/Systems Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Pulmonary Drug Delivery Devices/Systems Price by Type (2017-2028) & (USD/Unit)
Figure 27. Product Picture of Hospitals and Clinics
Figure 28. Product Picture of Homecare
Figure 29. Global Pulmonary Drug Delivery Devices/Systems Market Share by Application in 2022 & 2028
Figure 30. Global Pulmonary Drug Delivery Devices/Systems Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2028) & (K Units)
Figure 33. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Pulmonary Drug Delivery Devices/Systems Price by Application (2017-2028) & (USD/Unit)
Figure 35. United States Pulmonary Drug Delivery Devices/Systems Market Share by Application in 2022 & 2028
Figure 36. United States Pulmonary Drug Delivery Devices/Systems Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Pulmonary Drug Delivery Devices/Systems Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2028) & (K Units)
Figure 39. United States Pulmonary Drug Delivery Devices/Systems Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Pulmonary Drug Delivery Devices/Systems Price by Application (2017-2028) & (USD/Unit)
Figure 41. North America Pulmonary Drug Delivery Devices/Systems Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 42. North America Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Pulmonary Drug Delivery Devices/Systems Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 46. Europe Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Pulmonary Drug Delivery Devices/Systems Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 53. Asia-Pacific Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Pulmonary Drug Delivery Devices/Systems Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 64. Latin America Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 69. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. UAE Pulmonary Drug Delivery Devices/Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Pulmonary Drug Delivery Devices/Systems Value Chain
Figure 74. Pulmonary Drug Delivery Devices/Systems Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed